BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

 

October 2006

TriMark Publications Announces Release of Its Avian Influenza Report

TriMark Publications Announces Release of Its Over-the-Counter Diagnostic Products World Markets Report

TriMark Publications Announces Release of Its Nutraceuticals and Dietary Supplements Markets Report

TriMark Publications Announces Release of Its Clinical Chemistry Analyzers Report

TriMark Publications Announces Release of Its Blood Glucose Testing and Diabetes Management Report

York Pharma (AIM:YRK): Product Update, Sabarep

deltaDOT announces move to Imperial Innovations BioIncubator

ORIDIS Biomed Licenses NIH's Proprietary Tissue Micro-Array Technology

Northbank Communications Strengthens Munich Team with New Appointment

LibraGen and sanofi-aventis sign research partnership to identify new candidate molecules for treatment of infectious diseases and cancer

Cytheris announces the successful completion of its second financing round for EUR 24.3M (USD 30.7M)

IntegraGen appoints Emmanuel Martin as Director for its new Genetic Research Services

Cytheris closes EUR 24.3M (USD 30.7M) Series B financing with ABN AMRO

Industry Welcomes European Parliament Hearing on Green Biotech

Europabio urges EU Parliament to increase 2007 EMEA budget

Global Pharmaceutical Outsourcing of Manufacturing / Sales & Marketing to Exceed $30 Billion by 2011

Auto-Montage Helps Generate Accurate 3D Insect Images For World’s Largest Hymenoptera Classification Programme

Thermo Introduces the Finntip Flex 1000 and Flex Filter tips - New high volume addition to the Finntip Flex family of pipette tips

SIGMA-PROLIGO EXPANDS INTO GENOPOLE D'EVRY BIOPARK

GE HEALTHCARE AND BAC ANNOUNCE STRATEGIC COLLABORATION IN BIOPHARMACEUTICAL PURIFICATION

Worldwide Obesity and Weight Loss Treatment to Reach $9 Billion by 2010

Global MRI Market Expected to Top $4 Billion by 2010

Worldwide Market for Women’s Pharmaceuticals to Top $63 Billion by 2010

$51 Billion Protein Therapeutics Market Set to Reach $87 Billion by 2010

Expanding World Radiography Market Relies on Both Traditional and Digital

Global Contract Drug Development Spending to Reach $42 Billion by 2010

Global Biosensor Sales to Exceed $4 Billion by 2009

U.S. Market for Psoriasis Therapeutics to Surpass $9 Billion by 2016

Quantum Genomics Corp Names Jean-Pierre Riffaud Head of Preclinical Development

deltaDOT strengthens management team with appointment of Operations Director and Chief Commercial Officer

SOLEXA ANNOUNCES SEQUENCING OF A HUMAN X-CHROMOSOME, LARGEST DNA SEQUENCING PROJECT TO DATE ON NEXT-GENERATION PLATFORM

Fully enclosed incubation chamber for the PerkinElmer UltraVIEW launched at Neuroscience 2006

Virax (ASX:VHL) lodges IND application with US FDA and extends rights issue

CAMBRIDGE ANTIBODY TECHNOLOGY AND MSM PROTEIN TECHNOLOGIES ENTER DRUG DISCOVERY COLLABORATION IN THE FIELD OF MULTI-SPANNING MEMBRANE PROTEINS

Cobra signs agreement with US Naval Medical Research Center to evaluate Cobra's oral vaccine delivery platform

CAMBRIDGE ANTIBODY TECHNOLOGY AND DEBIOPHARM GROUP ENTER INTO AN EXCLUSIVE AGREEMENT TO DEVELOP AND MARKET SC-1 FOR GASTRIC CANCER

ABLYNX EXPANDS AND RELOCATES TO NEW FACILITIES

Ovarian cancer: platinum-based therapy still the gold standard

 TTP LABTECH - ESKITIS INSTITUTE ENHANCED BY FLEXIBLE COMPOUND PROCESSING SOLUTION

York Pharma Announces Placing of New Equity

Fourth New Fluorescence Application of Dyversity Makes Image Analyser Best in Class for 1D and 2D Protein Gel Imaging

Claus Braestrup, CEO of Lundbeck, appointed to Santaris Pharma Board

BioInvent Interim Report: 1 January - 30 September 2006

Phosphagenics' transdermal insulin clinical trial confirms successful delivery of insulin across skin in humans

Phosphagenics assigns license for Phospha-E

LifeCycle Pharma enters Three Distinct Strategic Collaboration Agreements with Global Pharmaceutical Companies

Industry Welcomes European Parliament Hearing on Green Biotech - Ten years of safe and sustainable GM crops production

International Biotechnology Trust Plc benefits as Pfizer makes acquistion

NAUTILUS BIOTECH ANNOUNCES IND FILING FOR ITS INJECTABLE LONG-LASTING INTERFERON-alpha, BELEROFONR

Phosphagenics: Favourable toxicology results support broadening transdermal morphine (TPM-01/Morphine) clinical program

mtm laboratories raises € 22 million in Series C financing

Xention initiates clinical development for atrial fibrillation treatment

Peakadilly awarded €1.7 million ($2.2 million) grant by Flanders Government to accelerate the development of its diagnostic and pharmacodiagnostic biomarker discovery platform

Schering-Plough: new fungicide gets US approval

OXFORD BIOMEDICA PRESENTS ENCOURAGING IMMUNOLOGICAL DATA FROM SIX PHASE II TRIALS OF TROVAX IN VARIOUS CANCERS

UNIQUE FLU VACCINE TRIAL T0 START IN LONDON - Opportunity to Trial New Vaccine That Could Help In the Fight Against Annual and Pandemic Flu

Girls on Top - Northbank Communications Strengthens Senior Team with Three Promotions

Institut Pasteur Korea selects ActivityBase™ as its Screening Solution of choice

Amsterdam Molecular Therapeutics BV Closes €22 Million Equity Financing

ABN AMRO Capital Life Sciences leads € 22 million investment in Amsterdam Molecular Therapeutics BV

Former SmithKline Beecham chairman Martin Greenacre to speak at 3rd Annual Asia Pacific Life Science Forum

Sigma-Aldrich Welcomes the University of Edinburgh to the RNAi Partnership Program

Mid pharma looks outside itself to drive revenue

ACTIVE BIOTECH SECTOR DRIVES PERFORMANCE OF INTERNATIONAL BIOTECHNOLOGY TRUST PLC (PRELIMINARY RESULTS)

New Application of CCD-based Image Analyser Offers Accurate Detection of Proteins Stained with Flamingo Fluorescent Dye

Eden Biodesign and Aquapharm BioDiscovery join forces to help combat MRSA

OXFORD BIOMEDICA EXPANDS ITS OCULAR PROGRAMME THROUGH COLLABORATION AND INVESTMENT LED BY THE FOUNDATION FIGHTING BLINDNESS

ORIDIS Biomed Appoints Wolfgang Senne as Chief Financial Officer

York Pharma provides regulatory update on lead product Abasol

POWDERMED TO CONDUCT U.S. CLINICAL TRIAL OF DNA-BASED ANNUAL INFLUENZA VACCINE - Study will assess immunogenicity, safety and tolerability of new, needle-free vaccine

Member States reach agreement on Framework Programme for Research and Innovation in Europe

SR PHARMA PLC UNAUDITED INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2006

October to December 2007 Biotechnology News

July to September 2007

April to June 2007

January to March 2007

BioNewsCast Press Release Service 2006 Archive - January 2006 ~ February 2006 ~ March 2006 ~ April 2006 ~ May 2006 ~ June 2006 ~ July 2006 ~ August 2006 ~ September 2006  ~ October 2006 ~ November - December 2006

BioNewsCast Press Release Service 2005 Archive - December 2005 ~ November 2005 ~ October 2005

BioNewsCast Press Release Service 2004 Archive

BioNewsCast Press Release Service 2003 Archive

BioNewsCast Press Release Service 2002 Archive

Site Map - new news site

Site Map - old news site
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.